All Articles
Our New Personalized Medicine Catchphrase: Like It, Learn It, Leverage It

Our New Personalized Medicine Catchphrase: Like It, Learn It, Leverage It

10 July, 2012

Mollie Roth discusses how the Diaceutics' catchphrase can sum up not only a positive commercialization approach for pharmaceutical companies and their relationship with personalized medicine, but also the history of the industry itself. Diaceutics has seen pharma start to like personalized medicine and then begin to learn it but observes that leveraging remains elusive, because to achieve it will require the greatest management change of all. 

Tags

Commercialization Pharmaceutical Expert Insights Personalized Medicine

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane
London
EC4V 5EQ.

Tel: +44 (0)20 3405 0205 or [email protected]


 
Caroline Forde
Robyn Fisher
 
Kieran Breheny